Cerebral and Tissue Oximetry Device Market Outlook:
Cerebral and Tissue Oximetry Device Market size was over USD 190.22 million in 2025 and is poised to exceed USD 377.7 million by 2035, witnessing over 7.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of cerebral and tissue oximetry device is estimated at USD 202.38 million.
A significant market driver is the increasing number of surgical procedures performed in traditional operating rooms and outpatient settings. In view of the increasing number of complex procedures, cerebral and tissue oximetry device play an important role in the monitoring of tissue oxygen levels during surgery, enabling surgeons to make informed decisions and potentially reduce complications. In comparison with the global estimate of 5000 surgeries for every 100,000 people, a total of 3646 procedures are expected each year to meet the needs of India's population.
The demand for cerebral and tissues oximetry devices is driven by a growing preference to non-invasive medical surveillance. These technologies are used by both patients and healthcare professionals, because they allow the provision of Realtime data that does not involve inoperative procedures, improve patient comfort and reduce potential risks resulting from traditional methods.
